Evidence map›Paper›PMID 14735325›Full record

ArticleImmunogenetics2004

Association of beta2-microglobulin with the alpha3 domain of H-2Db heavy chain.

Mirjana Lilić, Zoran Popmihajlov, John J Monaco, Stanislav Vukmanović

Abstract read
PubMed Publisher
In one paragraph

Article in Immunogenetics, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mirjana LilićMichael Heidelberger Division of Immunology, Department of Pathology and NYU Cancer Center, NYU School of Medicine, New York, NY 10016, USA.
Zoran Popmihajlov
John J Monaco
Stanislav Vukmanović

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Drew R Jones · 1985 to 2026
$83.1M
RECEPTOR/LIGAND INTERACTIONS IN T CELL DIFFERENTIATIONR01AI041573 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI VUKMANOVIC, STANISLAV · 1998 to 2007
$1.7M
DYNAMICS OF PERIPHERAL T CELL REPERTOIRER01AI048837 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI VUKMANOVIC, STANISLAV · 2002 to 2006
$1.7M
NCI NIH HHS 5P30 CA16087NIAID NIH HHS AI41573NIAID NIH HHS AI48837
6 · The paper itself

Abstract

MHC class I molecules are heterotrimeric complexes composed of heavy chain, beta2-microglobulin (beta2m) and short peptide. This trimeric complex is generated in the endoplasmic reticulum (ER), where a peptide loading complex (PLC) facilitates transport from the cytosol and binding of the peptide to the preassembled ER resident heavy chain/beta2m dimers. Association of mouse MHC class I heavy chain with beta2m is characterized by allelic differences in the number and/or positions of amino acid interactions. It is unclear, however, whether all alleles follow common binding patterns with minimal contributions by allele-specific contacts, or whether essential contacts with beta2m are different for each allele. While searching for the PLC binding site in the alpha3 domain of the mouse MHC class I molecule H-2Db, we unexpectedly discovered a site critical for binding mouse, but not human, beta2m. Interestingly, amino acids in the corresponding region of another MHC class I heavy chain allele do not make contacts with the mouse beta2m. Thus, there are allelic differences in the modes of binding of beta2m to the heavy chain of MHC class I.

Indexed as

AnimalsATP-Binding Cassette Transportersbeta 2-MicroglobulinCattleH-2 AntigensHistocompatibility Antigen H-2DHumansMicePoint MutationPrecipitin TestsProtein Structure, TertiaryProtein TransportRecombinant Fusion ProteinsATP-Binding Cassette Transportersbeta 2-MicroglobulinH-2 AntigensHistocompatibility Antigen H-2DRecombinant Fusion Proteins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.